We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Partial failure of CPAP treatment for sleep apnoea: Analysis of the French national sleep database.
- Authors
Bailly, Sébastien; Daabek, Najeh; Jullian‐Desayes, Ingrid; Joyeux‐Faure, Marie; Sapène, Marc; Grillet, Yves; Borel, Jean‐Christian; Tamisier, Renaud; Pépin, Jean‐Louis
- Abstract
Background and objective: Continuous positive airway pressure (CPAP) is the first‐line therapy for obstructive sleep apnoea (OSA). Residual apnoea and/or hypopnoea events, that is an apnoea–hypopnoea index (AHI) > 5, during CPAP contribute to treatment drop‐out. The clinical scenarios triggering residual events during CPAP use are poorly described. Underlying co‐morbidities, especially cardiovascular diseases, lifestyle factors, OSA characteristics at diagnosis and type of mask have been suggested as potential contributors. Methods: Patients from the prospective French sleep apnoea registry diagnosed with OSA (AHI ≥ 15 events/h) treated with CPAP were included. Logistic regression analysis identified factors associated with a risk of residual AHI > 5 events/h on CPAP. Results: The 12 285 OSA patients were predominantly men (n = 8715, 70.9%), middle‐aged (58.2 (49.8; 66.1) years) and obese (median body mass index: 31.3 (27.7; 35.6) kg/m2). Most had an AHI ≤ 5 events/h (n = 9573, 77.9%) versus 22.1% with AHI > 5/h. The latter were less CPAP adherent (5.75 (4.01; 7.00) vs 6.00 (4.53; 7.00) h/night). In multivariable analysis, factors associated with residual AHI >5/h were male sex, age, sedentary lifestyle, OSA severity, cardiovascular co‐morbidities (heart failure and arrhythmia) and type of interface (orofacial mask versus nasal mask: OR = 2.15 (95%CI: 1.95; 2.37)). A subgroup analysis found that patients using pressures above 10 cm H2O were 1.43 (95% CI: 1.3; 1.57) times more likely to have residual AHI > 5/h. Conclusion: Knowing about risk factors for residual apnoeic–hypopnoeic events may assist in the timely provision of personalized care including the type of PAP therapy, attention to co‐morbidities and choice of interface.
- Subjects
CONTINUOUS positive airway pressure; APNEA; CARDIOVASCULAR diseases; BODY mass index; LOGISTIC regression analysis; SLEEP; ATRIAL arrhythmias
- Publication
Respirology, 2020, Vol 25, Issue 1, p104
- ISSN
1323-7799
- Publication type
Article
- DOI
10.1111/resp.13650